Zennova Pharma Group’s China facility is in production recently. Its 350,000 SQF state-of- the-art cGMP facility will support US & global markets for various of Rx products.

Zennova PharmaceuticalrecentlyannouncedapartnershipwithInnogenix,aleadingpharmaceuticalcompanydintheUnitedStates.ThecollaborationgrantsZennovavariesofrightstoaccesstencutting-edgeRxproductsdevel...

Zennova Pharma Group recently achieved a significant milestone by successfully completing a Series B fundraising round of over 15 million dollars.

At the start of the new year and on the morning of January 11, 2023, the groundbreaking ceremony for Zennova Pharmaceutical’ manufacturing plant and R&D center interior construction project was held

Zennova Pharmaceutical (Chengdu) Co., Ltd. (referred to as "Zennova") has successfully achieved the esteemed status of "The National High-Tech Enterprises" in 2022.

The2021TianfuIntellectualPropertySummitwasheldinChengduonSeptember23,2021.LuoQiang,ViceGovernorofSichuanProvince,GanShaoning,DeputyDirectoroftheChinaNationalIntellectualPropertyAdministration,andLiuHu...

Zennova Pharmaceutical has successfully completed its Series A fund raising of tens of millions of RMB from Dyee Capital, the lead investor, and Shining Capital,the co-investor, on August 23, 2021.